drugset

drugset / Trial / NCT00189787

Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

NCT00189787 ↗

Phase 2 Completed 370 enrolled Astellas Pharma Inc Astellas Pharma Europe B.V. · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the efficacy and safety of tacrolimus in patients with asthma.

Timeline

Start: —
Primary completion: 2005-08
Completion: 2005-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tacrolimus	Small molecule	—	—

Indications